Determination of ELISA reactive mumps IgG antibodies in MMR vaccine recipients in comparison with MMR vaccine naive children: A cross sectional study
Background/Aim: Mumps is by vaccine preventable infectious disease characterised by parotitis. In India mumps vaccines are not currently used under National Immunisation Programme (NIP). Waning of vaccine-induced immunity is considered to play a central role in the re-emergence of mumps. The compreh...
Main Authors: | Gupta Riya, Saxena Naveen, Gupta Parul |
---|---|
Format: | Article |
Language: | English |
Published: |
Medical Society of the Republic of Srpska, Banja Luka, University of Banja Luka. Faculty of Medicine
2021-01-01
|
Series: | Scripta Medica |
Subjects: | |
Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/2490-3329/2021/2490-33292103174G.pdf |
Similar Items
-
Response to Measles, Mumps and Rubella (MMR) Vaccine in Transfusion-Dependent Patients
by: Maddalena Casale, et al.
Published: (2021-05-01) -
Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients
by: Jeffrey E. Gold, et al.
Published: (2020-12-01) -
The effectiveness of measles-mumps-rubella (MMR) vaccination in the prevention of pediatric hospitalizations for targeted and untargeted infections: A retrospective cohort study
by: Giuseppe La Torre, et al.
Published: (2017-08-01) -
Clinical trials show similar safety outcomes including febrile convulsion rates for GSK’s and Merck’s measles-mumps-rubella (MMR) vaccines
by: Md Ahsan Habib, et al.
Published: (2023-01-01) -
Development and Use of an Endpoint Titration Assay To Characterize Mumps IgG Avidity following Measles, Mumps, and Rubella Vaccination and Wild-Type Mumps Infection
by: Sara Mercader, et al.
Published: (2018-10-01)